Although at the beginning of the Project the COVID19 pandemic affected some of the activities, we managed to organize activities and personnel to maximize the group performance. During the Project we have generated transgenic plants specifically tailored for each objective, among others plants expressing markers for cell cycle analysis, chromatin modifying enzymes targeted to specific genomic locations, and testing a collection of mutants for phenotypic characteristics towards resistance to abiotic stress using molecular, cellular, genetic and genomic strategies. The main results achieved so far and their dissemination are:
- Generation of the PlaCCI reporter line (Nat Plants 2020), a useful tool used now in ~200 laboratories worldwide, and recognized by the community (Roeder A & Clark F: Faculty Opinions Recommendation, In Faculty Opinions, 16 Nov 2020; 10.3410/f.738749588. 793579825), instrumental for several other publications and parts of the project.
- The EMBO J review (2020) defined the key patwhays of the cell cycle controlled by the retinoblastoma protein.
- Evolutionary features of ORC proteins, protein domains and their relevance in DNA replication (Genome Biol Evol 2020).
- We defined the distinct roles of ORC1a and ORC1b, two DNA replication initiation proteins in heterochromatin maintenance and DNA replication, respectively (Nat Comm 2023).
- We found a diurnal control of deposition of the histone mark H3K27me1 relevant for controlling the expression of DNA damage response genes (Pkant J 2024).
- We identified the role of the histone variant H3.14 expressed in endoreplicating cells and required for the early response to abiotic stress to repress cell division and stimulate the expression of stress reposnse genes (Dev Cell 2025).
- We defined a novel regulatory step of cell proliferation during root growth and established that stem cell derivatives have a long G1 compared to cells developing their last cell cycle before entering differentiation by a mechanism involved a direct relationship between stem cell regualtors and the retinoblastoma pathway (Nat Plants 2025, still in press).